FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2023/10/058659 [Registered on: 13/10/2023] Trial Registered Prospectively
Last Modified On: 18/09/2023
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Ayurveda 
Study Design  Randomized, Parallel Group, Active Controlled Trial 
Public Title of Study   to see the Effect of Drakshadi Siddha Aschyotana in Pittaj Abhishyanda that is Conjunctivitis 
Scientific Title of Study   Randomized open controlled clinical trial to evaluate the efficacy of drakshadi siddha dugdha aschyotana in pittaj abhishyanda with special reference to acute mucopurulent conjunctivitis. 
Trial Acronym  Nil 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Ketan Krishna Dhainje 
Designation  PG Scholar 
Affiliation  Hon Shri Annasaheb Dange Ayurved Medical College Post Graduate and Research Center Ashta 
Address  Opd no 2 Netra rog OPD Ground Floor Dhanvantari Ayurvedic Hospital Ashta Tal Walwa Dist Sangli
Opd no 2 Netra rog OPD Ground Floor Dhanvantari Ayurvedic Hospital Ashta Tal Walwa Dist Sangli
Sangli
MAHARASHTRA
416301
India 
Phone  9766508163  
Fax    
Email  ketand32@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr. Pournima Fasale 
Designation  Associate Professor 
Affiliation  Hon Shri Annasaheb Dange Ayurved Medical College Post Graduate and Research Center Ashta 
Address  2nd Floor Department of Shalakyatantra Hon Shri Annasaheb Dange Ayurved Medical College Post Graduate and Research Center Ashta Tal Walwa Dist Sangli

Sangli
MAHARASHTRA
416301
India 
Phone  9373079219  
Fax    
Email  pournimafasale33@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Pournima Fasale 
Designation  Associate Professor 
Affiliation  Hon Shri Annasaheb Dange Ayurved Medical College Post Graduate and Research Center Ashta 
Address  2nd floor Department of Shalakyatantra Hon Shri Annasaheb Dange Ayurved Medical College Post Graduate and Research Center Ashta
2nd floor Department of Shalakyatantra Hon Shri Annasaheb Dange Ayurved Medical College Post Graduate and Research Center Ashta
Sangli
MAHARASHTRA
416301
India 
Phone  9373079219  
Fax    
Email  pournimafasale33@gmail.com  
 
Source of Monetary or Material Support  
Hon Shri Annasaheb Dange Ayurved Medical College Post Graduate and Research Center Ashta 
 
Primary Sponsor  
Name  Dr Ketan Krishna Dhainje 
Address  OPD no 2 Ophthalmology OPD Ground Floor Dhanvantari Ayurved Hospital Ashta Tal Walwa Dist Sangli  
Type of Sponsor  Other [Self] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Ketan Krishna Dhainje  Hon Shri Annasaheb Dange Ayurved Medical College Post Graduate and Research Center Ashta  OPD no 2 Ophthalmology OPD Ground floor Dhanvantari Ayurved Hospital Ashta Tal Walwa Dist Sangli
Sangli
MAHARASHTRA 
9766508163

ketand32@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Hon Shri Annasaheb Dange Ayurved Medical College Post Graduate and Research Center Ashta Institutional Ethics Committee  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:H100||Mucopurulent conjunctivitis. Ayurveda Condition: ABISHYANDAH,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Intervention ArmProcedure-AScyotanam, आश्च्योतनम् (Procedure Reference: Vagbhat sutra sthan 23/1 , Procedure details: Keep the patient in lying down, relaxed position. With left hand open the left eye of the patient. With the help of Pichu or Varti, instil the medicated drops at the inner canthus from the distance of 2 angulas. Depending upon Dosha, & disease determine the dose of drug and retaining time. Extra liquid should be soaked with clean & soft cloth.)
(1) Medicine Name: Drakshadi siddha dugdha , Reference: Yogratnakar netrarog chikitsa page 288, Route: Topical, Dosage Form: Bindu/ Drops/ Spray (Karna/ Nasa/ Netra/ Mukha), Dose: 12(drops), Frequency: od, Duration: 2 Days
2Comparator ArmProcedure-AScyotanam, आश्च्योतनम् (Procedure Reference: vagbhat sutra sthan 23/1, Procedure details: Keep the patient in lying down, relaxed position. With left hand open the left eye of the patient. With the help of Pichu or Varti, instil the medicated drops at the inner canthus from the distance of 2 angulas. Depending upon Dosha, & disease determine the dose of drug and retaining time. Extra liquid should be soaked with clean and soft cloth.)
(1) Medicine Name: Nimbpatra swaras , Reference: Yogratnakar netrarog chikitsa page 388, Route: Topical, Dosage Form: Bindu/ Drops/ Spray (Karna/ Nasa/ Netra/ Mukha), Dose: 12(drops), Frequency: od, Duration: 2 Days
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  60.00 Year(s)
Gender  Both 
Details  1 Shows symptoms of Acute Mucopurulent Conjunctivitis
2 Patient with age above 18 years
3 Patient irrespective of Gender educational socioeconomic marital and caste status 
 
ExclusionCriteria 
Details  1 Any other active acute infective ocular disease
2 Recently operated eye
3 Patient having systemic disease
 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Case Record Numbers 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
To evaluate the efficacy of Drakshadi Siddha Dugdha Aschyotana in Pittaj Abhishyanada with special reference to Acute Mucopurulent Conjunctivitis.  4 weeks 
 
Secondary Outcome  
Outcome  TimePoints 
To review the literature of Pittaj Abhishyanda & Acute Mucopurulent
Conjunctivitis.
To study the adverse effects of Drakshadi Siddha Dugdha Ashchyotana in
Pittaj Abhishyanda with special reference to Acute Mucopurulent
Conjunctivitis if there any. 
4 weeks 
 
Target Sample Size   Total Sample Size="84"
Sample Size from India="84" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2/ Phase 3 
Date of First Enrollment (India)   20/10/2023 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   As we see the number of patients suffering from Acute mucopurulent conjunctivitis are increasing nowadays due to pollution and exposure to various organisms
So in this study we are going to evaluate the efficacy of Drakshadi Siddha Dugdha Aschyotana in case of Pittaj Abhishyanda with special reference to Acute Mucopurulent Conjunctivitis
Drakshadi Siddha Dugdha Aschyotana will be done 12 bindu retained for 300 matras for two days in the afternoon time in Trial group
In control group Nimba patra swaras Aschyotana will be done 12 bindu retained for 300 matras for two days in the afternoon
Both groups will be assessed on 10th and 15th day for signs and symptoms and effect will be noted
 
Close